Other News New Advocacy Website Launched
Scientific Updates
FDA Approves Xeomin for the Treatment of Cervical Dystonia and Blepharospasm
Research Opportunity in Spasmodic Dysphonia
NSDA Funds New Research Grant on Spasmodic Dysphonia
Dystonia Awareness Week: June 6-12
Message from NSDA's New President - Charlie Reavis
The Congressionally Directed Medical Research Program Adds Dystonia to the List
NIH Funds $6.2 Million Dollar Grant for Focal Dystonias
Spasmodic Dysphonia and Quality of Life Research Study Results
Botulinum Toxin Update
NSDA Funds Research Grant
Brainstem Pathology in Spasmodic Dysphonia
Research Priorities in Spasmodic Dysphonia
Participate in the 2010 Dystonia Advocacy Day
Share Your Story Winner Announced
The Experience and Impact of Reading the "Share Your Story" Entries
Spasmodic Dysphonia Featured on ABC's Medical Mysteries Program
Changes in the Brain Identified in SD
SD Research Program Launched and Scientific Advisory Board Appointed
CEU Course Available on Spasmodic Dysphonia
Easier Done than Said...Living with a Broken Voice: New Book on Spasmodic Dysphonia
Emily Lim finds her Voice through Writing
Safety Issues Regarding Botulinum Toxin
ASHA provides Insurance Checklist for Speech Therapy Benefits
Comments
|
|
Research Opportunity in Spasmodic Dysphonia
A new research study for Adductor Spasmodic Dysphonia are currently recruiting in the New York City area.
We are looking to better understand motor control in adductor spasmodic dysphonia (ADSD) by examining the voice changes that occur when people speak using different vocal pitches. Research will be conducted at New York University or in approved Ear, Nose, and Throat offices in the New York area. The time commitment will be one visit lasting less than 2 hours.
Participant criteria includes adults diagnosed with adductor spasmodic dysphonia with no history of surgery to treat ADSD (e.g. recurrent laryngeal nerve surgery), either no history of the use of botulinum toxin injections or in the past 3 years or more, no diagnosed reflux, no diagnosed neurological disorders/conditions besides ADSD that could affect speech production (e.g. Parkinson's disease, brain injury, stroke, essential tremor), no diagnosed respiratory disorders (e.g. chronic obstructive pulmonary disease, asthma), no diagnosed speech disorders (e.g. articulation disorder, dysarthria), no diagnosed voice disorder other than ADSD, normal language ability, and native speakers of American English.
If you are interested in participating or learning more, please contact:
Primary Investigator: Heather Henry, M.A., CCC-SLP, doctoral student
Phone: 917-848-6954
Email: hmh261@nyu.edu
Faculty Sponsor: Dr. Celia Stewart
The NSDA provides information on this research study in order to further the scientific understanding of spasmodic dysphonia, but the NSDA does not endorse or recommend participation in this or any other medical research studies.
|
